calquencehcp.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /404.html Disallow: /404 Disallow: /500.html Disallow: /500 Disallow: /thank* Sitemap:
Meta Tags
Title R/R MCL and CLL/SLL Treatment | CALQUENCE® (acalabrutinib) 100 mg tablets | For
Description LEADING A NEW ERA IN BTK CALQUENCE® (acalabrutinib) is a BTK inhibitor indicated for the treatment of adult patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or R/R Mantle Cell Lymphoma
Keywords N/A
Server Information
WebSite calquencehcp faviconcalquencehcp.com
Host IP 54.239.174.12
Location United States
Related Websites
Site Rank
More to Explore
calquencehcp.com Valuation
US$15,643,993
Last updated: 2023-04-28 21:52:48

calquencehcp.com has Semrush global rank of 676,573. calquencehcp.com has an estimated worth of US$ 15,643,993, based on its estimated Ads revenue. calquencehcp.com receives approximately 1,805,077 unique visitors each day. Its web server is located in United States, with IP address 54.239.174.12. According to SiteAdvisor, calquencehcp.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$15,643,993
Daily Ads Revenue US$14,441
Monthly Ads Revenue US$433,219
Yearly Ads Revenue US$5,198,620
Daily Unique Visitors 120,339
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
calquencehcp.com. A 299 IP: 54.239.174.12
calquencehcp.com. A 299 IP: 54.239.174.47
calquencehcp.com. A 299 IP: 54.239.174.4
calquencehcp.com. A 299 IP: 54.239.174.76
calquencehcp.com. NS 86400 NS Record: ns-154.awsdns-19.com.
calquencehcp.com. NS 86400 NS Record: ns-1775.awsdns-29.co.uk.
calquencehcp.com. NS 86400 NS Record: ns-979.awsdns-58.net.
calquencehcp.com. NS 86400 NS Record: ns-1229.awsdns-25.org.
HtmlToTextCheckTime:2023-04-28 21:52:48
Toggle navigation FOR US HEALTHCARE PROFESSIONALS ONLY Medical Resources Prescribing Information Patient Website Request Samples Request a Rep CHOOSE INDICATION CLL/SLL R/R MCL FOR US HEALTHCARE PROFESSIONALS ONLY Medical Resources Prescribing Information Patient Website Request Samples Request a Rep CHOOSE INDICATION CLL/SLL R/R MCL R/R MCL APPROVED INDICATIONS KINASE SELECTIVITY DOSING & ADMINISTRATION SUPPORT & RESOURCES SUPPORT & RESOURCES Patient Support Patient Profiles Educational Resources Request a Rep More Hide FOR US HEALTHCARE PROFESSIONALS ONLY Medical Resources Prescribing Information Patient Website Request Samples Request a Rep CHOOSE INDICATION CLL/SLL R/R MCL EXPLORE THE TABLET FORMULATION: NO RESTRICTIONS WITH PPIs 1 > LEADING A NEW ERA IN BTK INHIBITION A next-generation selective BTK inhibitor 2 Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) 1 Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL) 1 Studied in multiple Phase 3 CLL trials with up
HTTP Headers
HTTP/1.1 403 Forbidden
Server: CloudFront
Date: Thu, 21 Oct 2021 21:17:45 GMT
Content-Type: text/html
Content-Length: 919
Connection: keep-alive
X-Cache: Error from cloudfront
Via: 1.1 c27b73b84ed8b00262acef150bb27b26.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: ORD53-C2
X-Amz-Cf-Id: vNRSuilJ7kaGk5uE2ulUIFYNxJZ3EpC6msMcoXRc47pj7gISjAZJdg==
calquencehcp.com Whois Information
Domain Name: CALQUENCEHCP.COM
Registry Domain ID: 2117856652_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-04-22T05:09:11Z
Creation Date: 2017-04-26T15:15:33Z
Registry Expiry Date: 2022-04-26T15:15:33Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-1229.AWSDNS-25.ORG
Name Server: NS-154.AWSDNS-19.COM
Name Server: NS-1775.AWSDNS-29.CO.UK
Name Server: NS-979.AWSDNS-58.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-10T16:20:03Z <<<